ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2022
Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster.
Almir Ribeiro da Silva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.